QualityStocksNewsBreaks Archives - Page 993 of 1497

TuesdayJun 09, 2020 12:10 pm

QualityStocksNewsBreaks – ISW Holdings’ (ISWH) JV Targeting Crypto Market Featured in Journal Transcript Article

International Spirits & Wellness Holdings (OTC: ISWH) (“ISW Holdings”), a top-tier brand incubator operating in the spirits, CBD-infused products, and home healthcare markets, was featured in a recent Journal Transcript article. The article, “ISWH and Bit5ive Team Up to Conquer the Crypto Mining Capex Opportunity” by Kyle Landeck focuses on ISW Holdings and its entrance into a new joint venture (“JV”) with Bit5ive LLC, a global leader in cryptocurrency mining and innovative turnkey mining solutions. “We are incredibly excited to expand our current portfolio and move into what we believe is a sector poised for strong technological and financial growth,”…

TuesdayJun 09, 2020 10:53 am

QualityStocksNewsBreaks – Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Announces Pricing of $6.4M Registered Direct Offering

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, today announced its entry into definitive agreements with investors for the purchase and sale of 6,400,000 of the Company’s American Depositary Shares (“ADSs”), each at a price of $1.00, pursuant to a registered direct offering. Foresight will secure approximately $6.4 million in gross proceeds from the offering, which it intends to use for working capital and other general corporate purposes. Subject to the satisfaction of customary conditions, the closing of the registered direct offering is expected to take place on or about June 11, 2020. A.G.P./Alliance Global…

TuesdayJun 09, 2020 10:34 am

QualityStocksNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Selected to Join Russell 3000(R) Index

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced that it is scheduled to join the U.S. broad-market Russell 3000 Index, which includes the 3,000 publicly traded companies on the Nasdaq and NYSE exchanges with the largest market capitalizations. According to the update and a preliminary list of additions, Genprex will join the index when FTSE Russell, a leading global index provider, reconstitutes its 2020 indices after the markets close on Friday, June 26, 2020. “The selection of Genprex for the Russell 3000(R) Index will add to the awareness…

TuesdayJun 09, 2020 10:28 am

QualityStocksNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Announces Retirement of CFO, Names Successor

Plus Products (CSE: PLUS) (OTCQX: PLPRF), a cannabis and hemp branded products company in the U.S., today announced that its Chief Financial Officer, Jon Paul, will be retiring at the end of this month. According to the update, current Vice President of Finance, Nate Pearson, has been identified as his successor, while Paul, following his retirement, will continue in an advisory role to ensure a smooth transition. “Jon has played an integral role in our organization since the day he joined,” Jake Heimark, co-founder and CEO of Plus Products, stated in the news release. “The financial and regulatory environments in…

TuesdayJun 09, 2020 9:45 am

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Financial Results for Q1 2020, Provides Business Update

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, on Monday reported financial results for the quarter ended March 31, 2020 and provided a business update. “We remain steadfast in our approach to assembling a portfolio of assets that leverages our unique collection of cancer tumors to develop and market AI-based, predictive models for personalized cancer treatments that improve patient outcomes,” Dr. Carl Schwartz, Predictive Oncology CEO, stated in the news release. “Our collection of more than 150,000 cancer tumors, amassed and curated over a 10-year period, gives us a…

MondayJun 08, 2020 12:28 pm

QualityStocksNewsBreaks – PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA) Accepts USD $2.7M Investment, Completes Mission to Offer Transformative Cloud-Based Platform

PowerBand Solutions (TSX.V: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA) today announced that its wholly-owned subsidiary, PowerBand Solutions US Inc. ("PowerBand US"), is accepting an additional USD $2.7-million investment from Texas-based D&P Holdings, Inc. ("D&P"), as it prepares for June vehicle lease originations in the United States. According PowerBand CEO Kelly Jennings, PowerBand has completed its more than two-year mission to offer a cloud-based platform that will transform the buying, selling, leasing and financing of vehicles. The platform removes unnecessary middlemen in the automotive retail sector and offers cloud-based solutions allowing automotive transactions to be carried out from any location, on smart…

MondayJun 08, 2020 11:48 am

QualityStocksNewsBreaks – CloudCommerce, Inc. (CLWD) Eyes Strong Trend to Digital Media, Acceleration Appears to be Helped by Pandemic

CloudCommerce (OTC: CLWD), a leading provider of digital advertising solutions, today announced that in spite of the economic downturn caused by the COVID-19 pandemic, the Company has recently increased revenue from its existing client base and added new clients within the past few weeks. “As was the case with most business leaders, our management team was concerned about the economic headwinds caused by the COVID-19 pandemic,” Andrew Van Noy, CEO of CloudCommerce, stated in the news release. “However, I am pleased to announce that our recent sales efforts have resulted in newfound revenue growth for CloudCommerce. As the economy begins…

MondayJun 08, 2020 11:11 am

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Engages Toronto-based Dalriada to Advance NCE IP Portfolio

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, today announced its selection of Toronto-based Dalriada Drug Discovery Inc. (“Dalriada”) to advance its new chemical entity (“NCE”) IP portfolio as it pertains to ketamine and psilocybin/psilicin molecular scaffolds. According to the update, Dalriada, a leading contract research organization (“CRO”) in the drug discovery space, will lead Champignon’s new drug discovery programs in the NCE arena and further provide integrated R&D support to accelerate the Company’s existing preclinical assets and ongoing development of proprietary delivery platforms. “It is with…

MondayJun 08, 2020 10:44 am

QualityStocksNewsBreaks – InsuraGuest Technologies Inc. (TSX.V: ISGI) Secures Utah Department of Insurance Approval of RPG Application

InsuraGuest Technologies (TSX.V: ISGI) today announced that the Utah Department of Insurance has found the Company’s wholly owned U.S. subsidiary InsuraGuest Risk Purchasing Group, LLC (“RPG”) to be in compliance with the requirements set forth in section 31A-15-201 of the Utah Code (the Risk Retention Groups Act). As of the acceptance date of June 4, 2020, RPG is registered and authorized to do business in Utah, with the Utah Insurance Department. “This is the last piece of the puzzle we needed to complete our Master Policy for our RPG’s Hospitality Liability coverages,” Douglas Anderson, chairman and CEO of InsuraGuest, stated…

MondayJun 08, 2020 10:11 am

QualityStocksNewsBreaks – Genprex, Inc.’s (NASDAQ: GNPX) Chairman and CEO to Present at the MoneyShow June Virtual Event

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced that it will present at the MoneyShow June Virtual Event at 12:50 p.m. EDT on Wednesday, June 10, 2020. According to the update, Genprex’s CEO and Chairman, Rodney Varner, will deliver a company overview and provide updates on its product pipeline, including its lead drug candidate, Oncoprex(TM) immunogene therapy, which received Fast Track Designation from the Food and Drug Administration for its combination therapy with AstraZeneca’s Tagrisso(R). He will also provide an overview of Genprex’s in-licensing of a preclinical gene…

Site Search

Company Search

Category: QualityStocksNewsBreaks